Most lately, it's been discovered that conolidine and the above mentioned derivatives act around the atypical chemokine receptor 3 (ACKR3. Expressed in very similar regions as classical opioid receptors, it binds to the wide array of endogenous opioids. Compared with most opioid receptors, this receptor acts being a scavenger https://erichv580wup0.bloguerosa.com/profile